×
Assembly Biosciences Receivables 2010-2025 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Assembly Biosciences receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Assembly Biosciences Receivables 2010-2025 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Assembly Biosciences receivables from 2010 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$21.2B
Dr Reddy's Laboratories (RDY)
$12.1B
BridgeBio Pharma (BBIO)
$9.4B
Bausch Health Cos (BHC)
$2.8B
Supernus Pharmaceuticals (SUPN)
$2.5B
Amphastar Pharmaceuticals (AMPH)
$1.4B
Taysha Gene Therapies (TSHA)
$818M
Personalis (PSNL)
$428M
Sol-Gel Technologies (SLGL)
$63M
Evoke Pharma (EVOK)
$9M
Teligent (TLGT)
$0M